<SEC-DOCUMENT>0001919246-26-000047-index.html : 20260401
<SEC-HEADER>0001919246-26-000047.hdr.sgml : 20260401
<ACCEPTANCE-DATETIME>20260401174539
ACCESSION NUMBER:		0001919246-26-000047
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20240614
FILED AS OF DATE:		20260401
DATE AS OF CHANGE:		20260401

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Friedberg Ezra M
		CENTRAL INDEX KEY:			0001679440
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41964
		FILM NUMBER:		26829696

	MAIL ADDRESS:	
		STREET 1:		1000 MARINA BOULEVARD
		STREET 2:		SUITE 250
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pelthos Therapeutics Inc.
		CENTRAL INDEX KEY:			0001919246
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				863335449
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4020 STIRRUP CREEK DRIVE
		STREET 2:		SUITE 110
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703
		BUSINESS PHONE:		919-908-2422

	MAIL ADDRESS:	
		STREET 1:		4020 STIRRUP CREEK DRIVE
		STREET 2:		SUITE 110
		CITY:			DURHAM
		STATE:			NC
		ZIP:			27703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Channel Therapeutics Corp
		DATE OF NAME CHANGE:	20241118

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Chromocell Therapeutics Corp
		DATE OF NAME CHANGE:	20220323
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>wk-form4a_1775079936.xml
<DESCRIPTION>FORM 4/A
<TEXT>
Document 1 - file: wk-form4a_1775079936.html

Document 1 - RAW XML: wk-form4a_1775079936.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>pths-section16_poaxv5xfrie.htm
<DESCRIPTION>EX-24
<TEXT>
Document 2 - file: pths-section16_poaxv5xfrie.htm

</DOCUMENT>
</SEC-DOCUMENT>